Cancer immune cell: what have scientists discovered?
Researchers say newly found T-cell appears to target multiple forms of the deadly disease
The discovery of a killer cell in the human immune system could lead to a “one-size-fits-all” cancer treatment, according to a newly published study.
The team of Cardiff University researchers who made the find say the T-cell has already been used in lab tests to attack and destroy prostate, breast, lung and other cancer cells.
Although no tests have been conducted yet on human patients, scientists say the findings - outlined in a newly published paper in the journal Nature Immunology - have “enormous potential”, the BBC reports.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
What have the researchers found?
One of the most groundbreaking advances in the fight against cancer in recent years is a treatment known as CAR-T immunotherapy. This therapy involves “harvesting a patient’s immune T-cells and reprogramming them to target specific proteins found on the patient’s cancer cells”, while leaving healthy cells undamaged, explains science news site New Atlas.
However, a major limitation facing researchers of CAR-T therapies has been the lack of a universal T-cell receptor (TCR) that can target different kinds of cancers in all patients.
But the T-cell discovered by the Welsh university team appears to be equipped with a new type of TCR that does exactly that.
This T-cell “recognises a molecule present on the surface of a wide range of cancer cells, and normal cells, and is able to distinguish between healthy and cancerous cells - killing only the latter”, The Independent reports.
In lab tests on mice and human cells, the T-cells equipped with the new TCR has been found to kill lung, skin, blood, colon, breast, bone, prostate, ovarian, kidney and cervical cancer cells.
And the reaction?
“If these sorts of effects can be replicated in humans,” says ScienceAlert, “we could be looking at a bright new future for T-cell treatments.”
According to Wales Online, experiments are under way to determine the precise molecular mechanism by which the new TCR distinguishes between healthy cells and cancer, and researchers hope to begin human patients towards the end of this year following further safety testing.
Cardiff University professor Awen Gallimore, a cancer immunology lead for the Wales Cancer Research Centre, said: “If this transformative new finding holds up, it will lay the foundation for a universal T-cell medicine, mitigating against the tremendous costs associated with the identification, generation and manufacture of personalised T-cells.
“This is truly exciting and potentially a great step forward for the accessibility of cancer immunotherapy.”
Alasdair Rankin of blood cancer charity Bloodwise added: “This research represents a new way of targeting cancer cells that is really quite exciting, although much more research is needed to understand precisely how it works.”
Create an account with the same email registered to your subscription to unlock access.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
-
Nigeria's worsening rate of maternal mortality
Under the radar Economic crisis is making hospitals unaffordable, with women increasingly not receiving the care they need
By Harriet Marsden, The Week UK Published
-
'Elevating Earth Day into a national holiday is not radical — it's practical'
Instant Opinion Opinion, comment and editorials of the day
By Harold Maass, The Week US Published
-
UAW scores historic win in South at VW plant
Speed Read Volkswagen workers in Tennessee have voted to join the United Auto Workers union
By Peter Weber, The Week US Published
-
Nigeria's worsening rate of maternal mortality
Under the radar Economic crisis is making hospitals unaffordable, with women increasingly not receiving the care they need
By Harriet Marsden, The Week UK Published
-
Dengue hits the Americas hard and early
Speed Read Puerto Rico has declared an epidemic as dengue cases surge
By Peter Weber, The Week US Published
-
How happy is Finland really?
Today's Big Question Nordic nation tops global happiness survey for seventh year in a row with 'focus on contentment over joy'
By Harriet Marsden, The Week UK Published
-
How Tehran became the world's nose job capital
Under the radar Iranian doctors raise alarm over low costs, weak regulation and online influence of 'Western beauty standards'
By Harriet Marsden, The Week UK Published
-
Africa's renewed battle against female genital mutilation
Under the radar Campaigners call for ban in Sierra Leone after deaths of three girls as coast-to-coast convoy prepares to depart
By Harriet Marsden, The Week UK Published
-
Argentina: the therapy capital of the world
Under the radar Buenos Aires natives go hungry to pay for psychoanalysis, amid growing instability, anxiety – and societal acceptance
By Harriet Marsden, The Week UK Published
-
Does declining birth rate spell doom for Britain?
Today's Big Question Ageing population puts pressure on welfare state, economy and fabric of society, while fertility is rising on populist agendas
By Harriet Marsden, The Week UK Published
-
How a new blood test could revolutionise sepsis diagnosis
The Explainer Early results from ongoing trial suggest faster identification of deadly condition is possible
By The Week Staff Published